BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 15786909)

  • 1. [Anesthesia in hereditary peripheral muscular disease].
    Islander G; Jungner M
    Lakartidningen; 2005 Feb 21-27; 102(8):566-71. PubMed ID: 15786909
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhalation anesthetics and Duchenne's muscular dystrophy.
    Goresky GV; Cox RG
    Can J Anaesth; 1999 Jun; 46(6):525-8. PubMed ID: 10391598
    [No Abstract]   [Full Text] [Related]  

  • 3. Volatile anesthetics and succinylcholine in cardiac ryanodine receptor defects.
    Swan H; Laitinen PJ; Toivonen L
    Anesth Analg; 2004 Aug; 99(2):435-7, table of contents. PubMed ID: 15271719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia and muscular dystrophies.
    Gurnaney H; Brown A; Litman RS
    Anesth Analg; 2009 Oct; 109(4):1043-8. PubMed ID: 19762730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duchenne muscular dystrophy: Which is the best anesthetic agent?
    Driessen J; Snoeck M
    Paediatr Anaesth; 2008 Oct; 18(10):1007-8. PubMed ID: 18811853
    [No Abstract]   [Full Text] [Related]  

  • 6. [Malignant hyperthermia].
    Glahn KP
    Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mild variant of malignant hyperthermia following succinylcholine and halogenated agent exposure].
    Fernández-García V; Bermejo MA; Vázquez C; Pereda MJ; Altarriba JM; Alvarez E
    Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):401-2. PubMed ID: 8584782
    [No Abstract]   [Full Text] [Related]  

  • 8. Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.
    Brandom BW; Muldoon SM
    Paediatr Anaesth; 2013 Sep; 23(9):851-4. PubMed ID: 23848295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation.
    Hogan KJ; Vladutiu GD
    Anesth Analg; 2009 Oct; 109(4):1070-2. PubMed ID: 19762733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant hyperthermia].
    Bouhajja B; Haddad F; Ben Ammar MS
    Tunis Med; 2002 Jul; 80(7):395-401. PubMed ID: 12611349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Helsinki Declaration on Patient Safety in Anaesthesiology - Part 3: SOP for malignant hyperthermia].
    Schuster F; Johannsen S; Roewer N
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Mar; 48(3):162-4. PubMed ID: 23592246
    [No Abstract]   [Full Text] [Related]  

  • 12. [Atypical malignant hyperthermia. A higher incidence than expected].
    Herrero E; Casinello F; de Stefano J; Fernández-Guisasola J; Pérez-Gallardo A
    Rev Esp Anestesiol Reanim; 1996 Jan; 43(1):42-3. PubMed ID: 8851836
    [No Abstract]   [Full Text] [Related]  

  • 13. Malignant hyperthermia during desflurane-succinylcholine anesthesia for orthopedic surgery.
    Garrido S; Fraga M; Martín MJ; Belda J
    Anesthesiology; 1999 Apr; 90(4):1208-9. PubMed ID: 10201695
    [No Abstract]   [Full Text] [Related]  

  • 14. [ENT anesthesia: the German Society of Anesthesia and Intensive Care Medicine on the use of succinylcholine].
    HNO; 1995 Nov; 43(11):640-1. PubMed ID: 8530309
    [No Abstract]   [Full Text] [Related]  

  • 15. Suxamethonium-induced rhabdomyolysis in a healthy middle-aged man.
    Le Puura AI; Koivisto P; Annila P
    Acta Anaesthesiol Belg; 2000; 51(1):51-3. PubMed ID: 10806523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia: how to spot it early.
    Haslego SS
    RN; 2002 Jul; 65(7):31-5; quiz 36. PubMed ID: 12136527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protocol to manage malignant hyperthermia with general anesthesia.
    Roberts MW
    Pediatr Dent; 1993; 15(1):45-6. PubMed ID: 7901841
    [No Abstract]   [Full Text] [Related]  

  • 18. Regarding: muscular dystrophy and the safety of inhalational agents.
    Schwartz D
    Paediatr Anaesth; 2007 Jan; 17(1):96; author reply 96-7. PubMed ID: 17184451
    [No Abstract]   [Full Text] [Related]  

  • 19. [General anesthesia in a patient homozygous for the atypical variant of plasma pseudocholinesterase].
    Bermejo MA; Bujarrabal J; Torres V; Rodríguez-Vigil I; Mekhitharian A; Nespral B
    Rev Esp Anestesiol Reanim; 1996; 43(6):224-5. PubMed ID: 8756241
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperkalaemic cardiac arrest in a manifesting carrier of Duchenne muscular dystrophy following general anaesthesia.
    Kerr TP; Duward A; Hodgson SV; Hughes E; Robb SA
    Eur J Pediatr; 2001 Sep; 160(9):579-80. PubMed ID: 11585084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.